MYC and cancer: Under conditions of replication stress or compromised repair capacity, these topoisomerase-mediated transient breaks can convert to permanent DNA lesions, directly contributing to the genomic instability that characterizes MYC-driven cancers (Figure 1) (Das et al., 2024).